Skip to main content
Journal cover image

Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells.

Publication ,  Journal Article
Lin, YM; Lim, JFY; Lee, J; Choolani, M; Chan, JKY; Reuveny, S; Oh, SKW
Published in: Cytotherapy
June 2016

Cartilage tissue engineering with human mesenchymal stromal cells (hMSC) is promising for allogeneic cell therapy. To achieve large-scale hMSC propagation, scalable microcarrier-based cultures are preferred over conventional static cultures on tissue culture plastic. Yet it remains unclear how microcarrier cultures affect hMSC chondrogenic potential, and how this potential is distinguished from that of tissue culture plastic. Hence, our study aims to compare the chondrogenic potential of human early MSC (heMSC) between microcarrier-spinner and tissue culture plastic cultures.heMSC expanded on either collagen-coated Cytodex 3 microcarriers in spinner cultures or tissue culture plastic were harvested for chondrogenic pellet differentiation with empirically determined chondrogenic inducer bone morphogenetic protein 2 (BMP2). Pellet diameter, DNA content, glycosaminoglycan (GAG) and collagen II production, histological staining and gene expression of chondrogenic markers including SOX9, S100β, MMP13 and ALPL, were investigated and compared in both conditions.BMP2 was the most effective chondrogenic inducer for heMSC. Chondrogenic pellets generated from microcarrier cultures developed larger pellet diameters, and produced more DNA, GAG and collagen II per pellet with greater GAG/DNA and collagen II/DNA ratios compared with that of tissue culture plastic. Moreover, they induced higher expression of chondrogenic genes (e.g., S100β) but not of hypertrophic genes (e.g., MMP13 and ALPL). A similar trend showing enhanced chondrogenic potential was achieved with another microcarrier type, suggesting that the mechanism is due to the agitated nature of microcarrier cultures.This is the first study demonstrating that scalable microcarrier-spinner cultures enhance the chondrogenic potential of heMSC, supporting their use for large-scale cell expansion in cartilage cell therapy.

Duke Scholars

Published In

Cytotherapy

DOI

EISSN

1477-2566

ISSN

1465-3249

Publication Date

June 2016

Volume

18

Issue

6

Start / End Page

740 / 753

Related Subject Headings

  • Transplantation, Homologous
  • Tissue Engineering
  • SOX9 Transcription Factor
  • S100 Calcium Binding Protein beta Subunit
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation
  • Matrix Metalloproteinase 13
  • Immunology
  • Humans
  • Glycosaminoglycans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lin, Y. M., Lim, J. F. Y., Lee, J., Choolani, M., Chan, J. K. Y., Reuveny, S., & Oh, S. K. W. (2016). Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells. Cytotherapy, 18(6), 740–753. https://doi.org/10.1016/j.jcyt.2016.03.293
Lin, Youshan Melissa, Jessica Fang Yan Lim, Jialing Lee, Mahesh Choolani, Jerry Kok Yen Chan, Shaul Reuveny, and Steve Kah Weng Oh. “Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells.Cytotherapy 18, no. 6 (June 2016): 740–53. https://doi.org/10.1016/j.jcyt.2016.03.293.
Lin YM, Lim JFY, Lee J, Choolani M, Chan JKY, Reuveny S, et al. Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells. Cytotherapy. 2016 Jun;18(6):740–53.
Lin, Youshan Melissa, et al. “Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells.Cytotherapy, vol. 18, no. 6, June 2016, pp. 740–53. Epmc, doi:10.1016/j.jcyt.2016.03.293.
Lin YM, Lim JFY, Lee J, Choolani M, Chan JKY, Reuveny S, Oh SKW. Expansion in microcarrier-spinner cultures improves the chondrogenic potential of human early mesenchymal stromal cells. Cytotherapy. 2016 Jun;18(6):740–753.
Journal cover image

Published In

Cytotherapy

DOI

EISSN

1477-2566

ISSN

1465-3249

Publication Date

June 2016

Volume

18

Issue

6

Start / End Page

740 / 753

Related Subject Headings

  • Transplantation, Homologous
  • Tissue Engineering
  • SOX9 Transcription Factor
  • S100 Calcium Binding Protein beta Subunit
  • Mesenchymal Stem Cells
  • Mesenchymal Stem Cell Transplantation
  • Matrix Metalloproteinase 13
  • Immunology
  • Humans
  • Glycosaminoglycans